Dr. Danielle Beckman, a Brazilian neuroscientist and leading neurovirology researcher, is pioneering studies on the impact of viral infections on brain health, particularly focusing on post-viral neurological symptoms.

Her research has shown that viruses like SARS-CoV-2 can infect neurons and trigger neuroinflammation within seven days, leading to rapid cognitive symptoms such as 'brain fog' in COVID-19 patients.

This work aims to bridge the gap in understanding the long-term neurological consequences of viral infections, with the goal of developing effective interventions for conditions like Long COVID and Alzheimer's disease.

Dr. Beckman is actively involved with the Long COVID community, emphasizing the importance of translational research and patient advocacy in her efforts.

At UC Davis, under the mentorship of Professor John Morrison, she has developed novel rhesus monkey models to study Alzheimer's disease, Long COVID, and viral-induced brain pathology.

These models are designed to better reflect human neurodegenerative processes, particularly through the expression of human-like tau proteins.

Her personal connection to dementia, influenced by her grandmother's experience, has intensified her curiosity about cellular mechanisms in neurodegenerative diseases.

As a Latina woman in STEM, Dr. Beckman advocates for diversity in science and mentorship, aiming to support underrepresented students in the field.

Her long-term research goals include addressing broader inflammatory processes that contribute to neurodegenerative diseases, focusing on developing effective therapies.

In an interview with Genomic Press Innovators & Ideas, Dr. Beckman discussed her findings on the links between viral infections and cognitive decline.

Her research on viral disruptions of brain homeostasis may lead to new treatment strategies for neurodegenerative diseases, highlighting the broader implications of her work.

As a member of the World Health Network's Long COVID advisory group, she advocates for patients and aims to translate her laboratory findings into impactful treatments.